Storia della carriera di Lyndsey Scull
Precedenti posizioni note di Lyndsey Scull
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Contatto Relazioni con gli Investitori | 01/12/2019 | 01/10/2021 |
| Public Communications Contact | 01/12/2019 | 01/10/2021 |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Lyndsey Scull
- Esperienza
